Asherson, Philip
Leaver, Laurence
Adamou, Marios
Arif, Muhammad
Askey, Gemma
Butler, Margi
Cubbin, Sally
Newlove-Delgado, Tamsin
Kustow, James
Lanham-Cook, Jonathan
Findlay, James
Maxwell, Judith
Mason, Peter
Read, Helen
van Rensburg, Kobus
Müller-Sedgwick, Ulrich
Sedgwick-Müller, Jane
Skirrow, Caroline
Article History
Received: 17 November 2021
Accepted: 27 September 2022
First Online: 11 October 2022
Declarations
:
: Not applicable. No experiments were conducted on humans requiring ethical review or consent to participate. The gathering and use of data from the consensus meeting for this report does not require approval by an ethics committee (ExternalRef removed). Those attending the consensus meeting informed that the discussion would be recorded when invited to the meeting, and on the day of the meeting gave their informed consent to recording of the meeting. This consent was given verbally.
: Not applicable.
: PA received honoraria for consultancy and educational talks from Janssen, Lily, Takeda/Shire, Medice and Flynn-pharma. KCL received financial support for education and research from Janssen, Takeda, Medice, Flynn pharma. MA received sponsorships to educational/scientific meetings and honoraria for consultancy and educational talks from Janssen, Lily, Takeda/Shire, and Flynn-pharma. TN-D received honoraria and non-financial support from Takeda/Shire for an educational meeting. USM was an advisory board member and received speaker honorarium and conference travel costs from Flynn Pharma, Medice and Takeda (Shire). KvR was a speaker at conferences sponsored by the Takeda, Flynn Pharma, Medice, Eli Lilly and Janssen, and was an advisor for Takeda, Flynn Pharma and Eli Lilly. CS is employed by Cambridge Cognition. PM received sponsorship for educational meetings and honoraria for consultancy and educational talks from Takeda (shire) and Flynn Pharma; PM works exclusively in private practice. JK works partly in private practice. HR works in private practice. The remaining authors report no competing interests.